The $100 billion dollar cholesterol-lowering statin drug industry is under attack, as thousands of Americans are filing lawsuits against the manufacturers cholesterol-lowering drugs such as Lipitor.
Millions of people over the age of 50 risk harming their health if they follow new NHS guidance telling them to take statins, leading doctors have warned the Health Secretary.
Reversing years of negative press on saturated fats, Time Magazine has finally admitted defeat on this issue, reversing course and admitting that the war on fat was wrong. They even expose the junk science that supports this dietary philosophy.
Not only has this bad/good cholesterol dichotomy been solidly debunked by study after study—it was never proven in the first place. The notion that saturated fats and LDL clog our arteries came from bad science and politics.
Dr. MaryAnne Demasi’s documentary on the criminal activity of the pharmaceutical industry regarding statin drugs sent shock waves through the mainstream media Her investigative reporting on the dangers of statin drugs has now been banned.
Dr. Fred Kummerow, who is alive and nearly 100 years old, was the first scientist to document the toxicity of trans fats. His work shows that it’s not cholesterol that causes heart disease; rather it’s the trans fats and oxidized cholesterol that are to blame.
A meta-analysis of 76 studies found current evidence does not support cardiovascular guidelines that encourage a low consumption of saturated fats. Saturated fat plays a crucial role in your body's development and day-to-day functioning for both children and adults.
Based on his own personal experience, Dr. David Diamond found that the idea of saturated fat and cholesterol causing heart disease was not based on any real science and is a myth.
This soft, waxy substance is found not only in your bloodstream but also in every cell in your body, where it helps to produce cell membranes, hormones, vitamin D, and bile acids that help you digest fat, and is vital for neurological function.
Compared with the older guidelines, new recommendations would increase the number of US adults eligible for statin therapy from 43.2 million to 56 million, with most of the increase occurring among adults without heart disease.